Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Holmes

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Neurobiology of Disease|March 22, 2022
Inflammation in dementia with Lewy bodiesJay Amin, Daniel Erskine, Paul C Donaghy, et al.
The Lancet. Neurology|March 17, 2007
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre studyIan McKeith, John O'Brien, Zuzana Walker, et al.
Acta Neuropathologica Communications|September 9, 2018
Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's diseaseSonja Rakic, Yat M A Hung, Matthew Smith, et al.
Journal of Psychopharmacology (Oxford, England)|January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for PsychopharmacologyJohn T O'Brien, Clive Holmes, Matthew Jones, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2008
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsLiping Huang, Sawsan Abuhamdah, Melanie-Jayne R Howes, et al.
Translational Psychiatry|May 26, 2019
Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairmentSultan Chaudhury, Keeley J Brookes, Tulsi Patel, et al.
The American Journal of Psychiatry|May 4, 2004
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodiesClive G Ballard, Robin Jacoby, Teodoro Del Ser, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2025
Periodontitis and incident cognitive decline and dementia: A 15-year prospective cohort study of older men residing in Northern IrelandDominic N Farsi, Rena Abadalkareem, Gerry J Linden, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 25, 2009
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)Clive Ballard, Richard Brown, Jane Fossey, et al.
Nature Reviews. Drug Discovery|November 6, 2012
Drug repositioning for Alzheimer's diseaseAnne Corbett, James Pickett, Alistair Burns, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Neurobiology of Disease|March 22, 2022
Inflammation in dementia with Lewy bodiesJay Amin, Daniel Erskine, Paul C Donaghy, et al.
The Lancet. Neurology|March 17, 2007
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre studyIan McKeith, John O'Brien, Zuzana Walker, et al.
Acta Neuropathologica Communications|September 9, 2018
Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's diseaseSonja Rakic, Yat M A Hung, Matthew Smith, et al.
Journal of Psychopharmacology (Oxford, England)|January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for PsychopharmacologyJohn T O'Brien, Clive Holmes, Matthew Jones, et al.
The Journal of Pharmacy and Pharmacology|October 30, 2008
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channelsLiping Huang, Sawsan Abuhamdah, Melanie-Jayne R Howes, et al.
Translational Psychiatry|May 26, 2019
Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairmentSultan Chaudhury, Keeley J Brookes, Tulsi Patel, et al.
The American Journal of Psychiatry|May 4, 2004
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodiesClive G Ballard, Robin Jacoby, Teodoro Del Ser, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2025
Periodontitis and incident cognitive decline and dementia: A 15-year prospective cohort study of older men residing in Northern IrelandDominic N Farsi, Rena Abadalkareem, Gerry J Linden, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 25, 2009
Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)Clive Ballard, Richard Brown, Jane Fossey, et al.
Nature Reviews. Drug Discovery|November 6, 2012
Drug repositioning for Alzheimer's diseaseAnne Corbett, James Pickett, Alistair Burns, et al.
Pageof 13